Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis.

Merkel, P A; Silliman, N P; Clements, P J; Denton, C P; Furst, D E; Mayes, M D; Pope, J E; Polisson, R P; Streisand, J B; Seibold, J R

Merkel, P A; Silliman, N P; Clements, P J; Denton, C P; Furst, D E; Mayes, M D; Pope, J E; Polisson, R P; Streisand, J B; Seibold, J R.

Affiliation

Merkel PA; Boston University, Boston, Massachusetts, USA. pmerkel@upenn.edu

Arthritis Rheum ; 64(10): 3420-9, 2012 Oct.

Article in En | MEDLINE | ID: mdl-22328195

Subject(s)

Clinical Trials as Topic; Scleroderma, Diffuse/drug therapy; Adult; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Scleroderma, Diffuse Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Arthritis Rheum Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google